Acquired factor V inhibitor presenting as life threatening bleeding after initiation of apixaban

Autor:	Gerard Chaaya, Veronica Guerra, Gliceida M Galarza Fortuna
Rok vydání:	2021
Předmět:	Oncology medicine.medical_specialty Pyridones business.industry MEDLINE Anticoagulants Factor V Hemorrhage Hematology General Medicine Factor V inhibitor Text mining Internal medicine medicine Humans Pyrazoles Apixaban business Genetics (clinical) medicine.drug
Zdroj:	Haemophilia. 27
ISSN:	1365-2516 1351-8216
DOI:	10.1111/hae.14374
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b9e502ce382bdd56ae906c170627898 https://doi.org/10.1111/hae.14374 Zobrazit plný text záznamu Plný text